Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BrainStorm Cell Therapeutics Appoints Alon Natanson as Chief Executive Officer

Published: Tuesday, January 29, 2013
Last Updated: Tuesday, January 29, 2013
Bookmark and Share
Mr. Natanson succeeds Dr. Adrian Harel, who will move into an executive scientific role in the company.

“Adrian Harel has led BrainStorm through a transforming period in the company’s history, both in terms of our clinical achievements as well as our financial security. We are pleased that he will be continuing to serve the company, albeit in a different capacity,” said Professor Avi Israeli, Chairman of the Board of Directors.

Prior to joining BrainStorm, Mr. Natanson, 49, successfully led large as well as early-stage companies in the fields of life science, high-tech, and retail. Previously, as Director of Marketing and Finance in Teva Pharmaceuticals’ Copaxone division, he played a key role in the commercialization of patented therapeutics for multiple sclerosis, establishing the division and executing its international strategy and product launch. Mr. Natanson has also led the successful turnaround of two insolvent American retail companies, transforming them into growing organizations with substantial gross margins. Since 2008, he served as President and CEO of Procognia.

“We are delighted to have Alon Natanson on board and warmly welcome him to BrainStorm,” added Professor Israeli. “We have full confidence in his leadership abilities to steer the company to successful completion of clinical development, regulatory approval and commercialization of our technology.”

“BrainStorm’s remarkable achievements to date demonstrate the company’s excellent scientific team and the huge potential of their technology,” commented Mr. Natanson. “I am excited to join the company at this critical stage, as its breakthrough stem cell candidate gets closer to becoming a part of tomorrow’s medicine.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,900+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

First Patient Enrolled in BrainStorm's Phase II ALS Trial
Patient enrollment in Phase II trial at Massachusetts General Hospital in Boston.
Tuesday, June 10, 2014
BrainStorm Establishes Safety of Repeat Doses of NurOwn in Mice
Pre-clinical study conducted at GLP-compliant Harlan Laboratories.
Friday, January 11, 2013
BrainStorm Announces Clinical Data for Safety and Supporting Efficacy of NurOwn™ Based on Initial Phase I/II Results
Data from patients in ALS Phase I/II human clinical trial treated with NurOwn™ technology do not show any side effects.
Wednesday, January 18, 2012
BrainStorm Cell Therapeutics Secures Funding to Reach Clinical Trials for ALS
New funding includes a grant from the Israeli government’s Office of the Chief Scientist and private investment.
Monday, September 07, 2009
BrainStorm Cell Therapeutics’ Adult Stem Cell Approach More Relevant than Embryonic Stem Cell Therapies
The Company claims that its adult stem cell therapies provide a safer approach at treating neurodegenerative diseases than competitive therapies that rely on embryonic stem cells.
Thursday, November 29, 2007
BrainStorm Cell Therapeutics Initiates Stem Cell Safety Study in Primates for Parkinson’s Disease
The Company has initiated a safety trial using an animal model of Parkinson’s disease in primates utilizing its adult stem cell technology.
Thursday, February 15, 2007
BrainStorm Targets Treatment of Stroke with its Adult Stem Cell Technology
BrainStorm’s bone marrow stem cell technology can differentiate adult stem cells into astrocyte-like cells.
Friday, August 25, 2006
BrainStorm Advances International Patent Application for Stem Cell Procedure
The patent protects a procedure for inducing bone marrow stem cells to differentiate into astrocytes.
Wednesday, July 12, 2006
Scientific News
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Improving Drug Production with Computer Model
A model has been developed that can be used to improve and accelerate the production of biotherapeutics, cancer drugs, and vaccines.
Defining Immortality of Stem Cells
Researchers defined the mechanisms underlying increased protein quality control of pluripotent stem cells.
BioCision Forms MedCision
The new company will focus on technologies for the management and automation of vital clinical processes.
Enhancing CRISPR to Explore Further
Researchers have developed sOPTiKO, a more efficient and controllable CRISPR genome editing platform.
Regenerating Diseased Hearts
Researchers from the University of Otago have probed the potential of adult stem cell types to repair diseased hearts.
Stem Cells Police Themselves to Reduce Scarring
Scientists have discovered stem cells in muscle fibers change gene expressions to respond to injury.
Bright Red Fluorescent Protein Created
Scientists have created a bright red, fluorescent protein that could be used to track essential cellular processes.
Protein Self-Regulates Abundance
Researchers have uncovered how a protein, that plays a crucial role in embryonic stem cell renewal, is regulated.
Topical Immunotherapy Effective Against Early Skin Cancer
Combination of two commonly used drugs triggers immune response against precancerous skin lesions.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!